USP9YP16

Across TCGA pan-cancer cohorts, USP9YP16 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated USP9YP16 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher USP9YP16 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP9YP16 expression acts as an unfavorable survival marker.

ESCA and STAD are the cancer types where USP9YP16 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	II,III,IV	0.124	0.703	<.001	90	view →
STAD	DFS	Tertile	All	0.149	0.634	<.001	51	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

USP9YP16–ESCA (OS)

Open the ESCA breakdown →